Digestive System Diseases  >>  tetomilast (OPC-6535)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tetomilast (OPC-6535) / Otsuka
NCT00064441: FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Completed
3
375
US
OPC-6535 Tablets (drug)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Ulcerative Colitis
05/06
05/06
NCT00064454 / 2005-003724-19: FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Completed
3
375
US
OPC-6535 Tablets (drug)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Ulcerative Colitis
07/06
07/06

Download Options